BiotechTube
Hycor Biomedical

Hycor Biomedical

Uden, Netherlands· Est.
hycorbiomedical.com
Is this your company? Claim your profile to update info and connect with investors.
Claim profile

Private Company

Funding information not available

Overview

Hycor Biomedical is a privately held, commercial-stage diagnostics company founded in 1985 and headquartered in Uden, Netherlands. It has established itself as a specialized player in the allergy diagnostics market with its flagship NOVEOS system, which addresses key laboratory challenges like small sample volume requirements and interference reduction. The company targets the growing global allergy testing market by providing solutions that enhance laboratory efficiency and diagnostic accuracy for physicians and patients. Its multi-national operational footprint supports its position as a global supplier in this niche segment.

Allergy

Technology Platform

NOVEOS Immunoassay Analyzer: An automated system for specific IgE testing using advanced micro-particle technology. Key features include a 4-μL sample volume, interference reduction from biotin, IgG/IgG4, and CCDs, high sensitivity, and up to 13 hours of walk-away operation.

Opportunities

The rising global prevalence of allergic diseases and increasing clinical awareness drive growing demand for accurate diagnostic testing.
The shift in laboratories toward automated, efficient, and interference-resistant platforms creates a direct market for the NOVEOS system's value proposition.
Hycor can leverage its focused expertise to capture market share from labs using older technologies and expand through new assay menu offerings.

Risk Factors

Intense competition from larger, diversified IVD corporations with greater resources poses a significant threat.
The company's reliance on the single NOVEOS platform creates concentration risk, where any product or commercial setback could have an outsized impact.
Rapid technological evolution in diagnostics risks obsolescence if innovation is not sustained.

Competitive Landscape

Hycor competes in the allergy diagnostics segment against major players like Thermo Fisher Scientific (via its Phadia business unit, a market leader with ImmunoCAP), Siemens Healthineers, and other companies offering specific IgE testing systems. Competition is based on test performance (sensitivity, specificity), menu breadth, automation, sample volume, interference handling, and total cost of ownership for laboratories.

More companies in Diagnostics & Precision Medicine →More companies in Netherlands →